A personalized, viable bone graft
BonoFill is an injectable high-density culture of regenerative cells derived from the patient’s adipose tissue and grown on a biocompatible 3-dimensional mineral scaffold.
What makes BonoFill™ so unique?
Broad applicability to all indications and bone gap sizes
Designed for bone reconstruction as a result of various bone diseases, applicable in variable sizes of damages.
Maxillofacial Bone Regeneration
Pre-transplant, all participants in our Phase II clinical trial for maxillofacial bone regeneration were diagnosed with a low-quality residual upper jawbone and insufficient bone height for dental implantation. However, within six months after BonoFill™, the patients’ bone height increased by an average of 9.2 mm, allowing the insertion of dental implants in 94% of the patients.
Broad applicability to all indications and bone gap sizes
Designed for bone reconstruction as a result of various bone diseases, applicable in variable sizes of damages.
Maxillofacial Bone Regeneration
Pre-transplant, all participants in our Phase II clinical trial for maxillofacial bone regeneration were diagnosed with a low-quality residual upper jawbone and insufficient bone height for dental implantation. However, within six months after BonoFill™, the patients’ bone height increased by an average of 9.2 mm, allowing the insertion of dental implants in 94% of the patients.
Pre transplant, the patient’s average residual bone height was 6.6 mm
3 months following BonoFillTM transplantation, average bone height was 14.8 mm
6 months following BonoFillTM transplantation, bone height 15.8 mm, demonstrating new bone growth of 9.2 mm
BonoFillTM – Orthopedic Indication
Critical Bone Defect, Preliminary Results - BNS05
|
Pre-Transplant
|
|
12 Months Post Transplant
|
|
Full load-bearing capacity 2.5 months after BonoFill™ transplantation
|
BonoFillTM – Orthopedic Indication
Critical Bone Defect, Preliminary Results - BNS05
|
Pre-Transplant
|
|
12 Months Post Transplant
|
|
Full load-bearing capacity 2.5 months after BonoFill™ transplantation
|
13 months post transplantation, the patient took part in the Iron Man competition
When Danny Yaakobson, an extreme sports enthusiast, suffered a serious leg injury following a car accident, he did not imagine he would become the world’s first patient to receive Bonus BioGroup’s lab-grown bone implant, made from his own fat cells, to replace a missing section of his shinbone, let alone take part in the ISRAMAN triathlon just a year following the surgery (as seen in the previous slide). The article on the left, was published in Ynet News, on 28.01.2019
info@bonus-bio.com
+972 (0)73 206 7104
Matam Advanced Technology
